Postponement of Biopharma Development & Production (BDP) China 2020: Informa Advisory and New Dates
With regards to the recent Coronavirus outbreak, we have been closely observing the situation, and in partnership with the relevant government authorities, agencies and our clients,, have put in place pre-event and onsite measures to help to ensure the safety and wellbeing of our participants.
Given recent developments in China, and keeping in mind the health and welfare of all conference participants, and implications for the Biopharma Development and Production China 2020 originally scheduled for 19th – 20th May 2020, we have decided to postpone the event, with the new dates confirmed for 3 – 4 November 2020 at Hilton Shanghai Hongqiao.
3 – 4 November being the main conference dates.
Kindly note the status on the co-located conferences:
- 10th Biomanufacturing Conference (Unchanged)
- 9th Cell Line Development & Engineering Asia (Unchanged)
- 11th Annual Biosimilars Asia (Cancelled)
- 2nd Cell and Gene Therapy Manufacturing (Newly added conference)
Finally, we wish to thank those who participate and support the Biopharma Development and Production China 2020 and we greatly appreciate your patience and understanding with our event postponement and look forward to your continued support. We would like to request you to lock in the above dates in your calendar so that we can continue the conference planning.
Our sole focus remains to provide an event of fantastic quality, with more participation from China and international pharma industry leaderships and qualified technology solution providers to make your attendance worthwhile.